在多发性硬化症的零星和家族病例中的认知障碍的比较研究
Vida Niakosari1, Ali Namjoo-Moghadam2, Ahmad Ali Abin3
1Faculty of Computer Science and Engineering, Shahid Beheshti University, Tehran, Iran.
Scientific reports
|January 4, 2025
概括
遗传学影响多发性硬化症 (MS). 这项研究发现,家族性和零星性MS患者表现出类似的认知障碍,两者的表现都比健康对照的表现更差. 教育和抑郁症等因素也会影响MS认知.
科学领域:
- 神经科学是一个神经科学.
- 遗传学 是一个遗传学.
- 临床神经学 临床神经学
背景情况:
- 遗传学有助于多发性硬化症 (MS) 风险,其中12.6%的病例具有家族因素.
- 以前的研究强调了家族性和零星性MS之间疾病进展和MRI发现的差异.
- 然而,这些MS亚型之间的认知障碍比较缺乏.
研究的目的:
- 评估和比较患有零星性MS,家族性MS和健康对照患者的认知表现.
- 调查家族性和零星性MS之间认知障碍的潜在差异.
- 确定与MS认知表现相关的因素.
主要方法:
- 在三个组中招募了130名参与者:零星性MS,家族性MS和健康的对照组,根据年龄,性别和教育情况进行匹配.
- 使用简要的MS国际认知评估 (BICAMS) 评估认知表现,包括符号数字模式测试 (SDMT),加利福尼亚语言学习测试 (CVLT) 和简要的视觉空间记忆测试修订 (BVMT-R).
- 分析认知数据以比较各组的表现,并确定教育,抑郁,年龄和性别等影响因素.
主要成果:
- 与健康对照组相比,家族性和零星性MS患者在SDMT,CVLT和BVMT-R上表现明显较差.
- 在所有测试的认知领域中,在家族性多发性硬化和零星性多发性硬化组之间没有发现认知障碍的统计学显著差异.
- 教育,抑郁,年龄和性别被确定为影响MS患者认知表现各方面的重要因素.
结论:
- 家庭和偶发性多发性硬化症患者表现出相似程度的认知障碍.
- 多发性硬化症的认知缺陷与家族病史的存在并没有显著的区别.
- 除了遗传倾向之外的因素,包括人口和心理变量,在多发性硬化症的认知结果中起着至关重要的作用.
相关概念视频
Alzheimer's Disease: Overview
1.7K
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
1.7K
Multiple Sclerosis l: Introduction
20
Multiple sclerosis is a chronic autoimmune disease of the central nervous system (CNS) that affects the brain, spinal cord, and optic nerves. It is an inflammatory demyelinating disorder and a leading cause of neurological disability in young adults.EpidemiologyMS commonly begins between 20 and 40 years of age and is twice as common in women. Its exact cause remains unclear, but genetic susceptibility contributes, with higher risk in first-degree relatives and identical twins. A greater...
20
Alzheimer Disease l: Introduction
21
Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...
21
Alzheimer Disease ll: Pathophysiology
35
Alzheimer disease involves structural changes in the brain that begin long before symptoms appear. The most distinctive features are extracellular neuritic plaques and intracellular neurofibrillary tangles.Neuritic plaques form in the cerebral cortex and around blood vessels. These plaques contain a dense core of beta-amyloid (Aβ)—a toxic protein fragment that clumps outside neurons. The core is surrounded by damaged neuronal extensions, as well as reactive astrocytes and...
35
Dementia l: Introduction
35
Dementia is an acquired, progressive syndrome characterized by a decline in multiple cognitive domains severe enough to impair daily functioning and reduce independence. Although memory loss is a central feature, the diagnosis requires additional deficits involving language, executive function, visuospatial skills, judgment, calculation, or abstract reasoning. These cognitive impairments reflect underlying neurodegenerative or vascular processes that gradually disrupt neuronal networks...
35


